Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Access Program
  4. /
  5. Kite Pharma, Inc. –...

Kite Pharma, Inc. – Relapsed/Refractory High-Grade B-Cell Lymphoma

Submitted By:
Published Date:
January 25, 2020

Access Program Information

A multicenter, open-label expanded access protocol for the treatment of subjects with
relapsed/refractory large B-cell lymphoma.

Rare Disease:
Spondyloepiphyseal dysplasia congenita Spondyloepiphyseal dysplasia- congenita

News

  • McGill University Study Reveals How the Gut Microbiome is Shaping the
  • Nanowire and Machine Learning Breakthrough Enables Early-Stage Cancer
  • Clinical Trial Shows Positive Results for Potential Treatment to Comba
More News

Events

  • The European Academy of Allergy and Clinical Immunology Congress (EAAC
  • The 18th World Congress of the International Society of Physical and R
  • The 33rd European Meeting on Hypertension and Cardiovascular Renal Pro
  • The ESMO Gastrointestinal Cancers Congress 2024 will take place in Mun
More Events
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2024 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo